ID   DPC-X4
AC   CVCL_D4ZJ
DR   CCRID; 4201PAT-CCTCC02620
DR   Wikidata; Q127380801
RX   PubMed=38253956;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023379.
CC   Population: Chinese.
CC   Doubling time: 70 hours (PubMed=38253956).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): PubMed=38253956
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 17
ST   D12S391: 21,22
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 15
ST   D1S1656: 17
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
RX   PubMed=38253956; DOI=10.1007/s13577-023-01023-0;
RA   Chai C.-P., Tang H., Yi J.-F., Li L., Yu C., Su Y.-H., Miao L.,
RA   Ye Z.-Z., Wang Z.-F., Luo W., Hu J.-J., Zhang H., Miao X., Xu H.,
RA   Zhou W.-C.;
RT   "Establishment and characterization of DPC-X4: a novel mixed-type
RT   ampullary cancer cell line.";
RL   Hum. Cell 37:531-545(2024).
//